A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection
Infectious Diseases and Therapy · 2025-01 · 14 (S1) · 39-61
DOI: 10.1007/s40121-024-01081-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infectious Diseases and Therapy, online erschienen am 30.12.2024. Verfasst von Angela Branche und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Rochester, Rochester, NY, USA. angela_branche@urmc.rochester.edu. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Rochester, Rochester, NY, USA. angela_branche@urmc.rochester.edu.
- Henry Ford Hospital, Detroit, MI, USA.
- Moderna Inc., Cambridge, MA, USA.
Zitieren
APA
Branche, A., Ramesh, M., & Francis, B. (2025). A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection. Infectious Diseases and Therapy, 14(S1), 39-61. https://doi.org/10.1007/s40121-024-01081-3
Vancouver
Branche A, Ramesh M, Francis B. A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection. Infectious Diseases and Therapy. 2025;14(S1):39-61. doi:10.1007/s40121-024-01081-3
BibTeX
@article{Branche2025,
author = {Branche, Angela and Ramesh, Mayur and Francis, Beverly},
title = {A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection},
journal = {Infectious Diseases and Therapy},
year = {2025},
volume = {14},
number = {S1},
pages = {39--61},
doi = {10.1007/s40121-024-01081-3}
}
EUVIMED